Form SCHEDULE 13D/A SOUNDTHINKING, INC. Filed by: Veradace Capital Management LLC
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
|
SOUNDTHINKING, INC. (Name of Issuer) |
Common stock, par value $0.005 per share (Title of Class of Securities) |
82536T107 (CUSIP Number) |
Alex Vezendan 3889 Maple Avenue, Suite 220 Dallas, TX, 75219 913-908-4943 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
02/27/2026 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 82536T107 |
| 1 |
Name of reporting person
Veradace Capital Management LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,089,805.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
16.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN, IA |
SCHEDULE 13D
|
| CUSIP No. | 82536T107 |
| 1 |
Name of reporting person
Veradace Partners LP | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,089,805.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
16.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. | 82536T107 |
| 1 |
Name of reporting person
John Conlin | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,089,805.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
16.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| CUSIP No. | 82536T107 |
| 1 |
Name of reporting person
Alex Vezendan | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,089,805.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
16.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common stock, par value $0.005 per share |
| (b) | Name of Issuer:
SOUNDTHINKING, INC. |
| (c) | Address of Issuer's Principal Executive Offices:
39300 CIVIC CENTER DRIVE, SUITE 300, 39300 CIVIC CENTER DRIVE, SUITE 300, FREMONT,
CALIFORNIA
, 94538. |
| Item 2. | Identity and Background |
| (a) | This Schedule 13D is being jointly filed by and on behalf of each of Veradace Capital Management LLC (Veradace), Veradace Partners L.P. (the Fund), Alexander Vezendan, and John Conlin. The Fund is the record and direct beneficial owner of the securities covered by this statement. As the general partner and the investment adviser to the Fund, Veradace may be deemed to beneficially own the securities covered by this statement. Messrs. Vezendan and Conlin are the Principals of, and may be deemed to beneficially own securities owned by, Veradace. The foregoing persons are hereinafter sometimes referred to as the Reporting Persons. Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. The filing of this statement shall not be construed as an admission that any Reporting Person is the beneficial owner of any of the shares of common stock that such Reporting Person may be deemed to beneficially own or that such Reporting Person is a member of a group with respect to the Issuer or any securities of the Issuer. |
| (b) | 3889 Maple Avenue, Suite 220, Dallas, TX 75219 |
| (c) | Each of the Reporting Persons is principally engaged in the business of acquiring, holding, voting and disposing of various public securities investments. |
| (d) | During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
| (e) | During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
| (f) | Veradace and the Fund are each organized under the laws of the State of Delaware. Messrs. Vezendan and Conlin are both citizens of the United States. |
| Item 3. | Source and Amount of Funds or Other Consideration |
As of March 6, 2026, the Fund, the record and direct beneficial owner of the securities covered by this statement, held voting and dispositive power over 2,039,805 shares of common stock of the Issuer ("Shares") and options to acquire 50,000 Shares (such shares and options collectively, the "Securities"), representing a combined total of 16.5 percent of the Issuer's outstanding Shares. All calculations of beneficial ownership percentages in this statement are based on 12,698,453 Shares outstanding as of November 6, 2025, as disclosed by the Issuer in its Form 10-Q filed with the SEC on November 13, 2025. Relevant transactions leading up to this date, as well as the respective price per share of each transaction, are set forth on Schedule A to this statement. Each of these transactions was executed through the open market. The funds for the purchase of the Securities came from the working capital of the Fund. The aggregate purchase price of the Securities reported herein was approximately $15,452,099. No borrowed funds were used to purchase the Securities, other than under margin accounts with a brokerage firm in the ordinary course of business. Positions in Issuer securities may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Such margin accounts may from time to time have debit balances. In addition, since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase the Securities. | |
| Item 4. | Purpose of Transaction |
Veradace originally acquired beneficial ownership of the Shares of the Issuer for investment purposes and filed a Schedule 13G on January 7, 2026 based on a passive investment intent.
Veradace evaluates on an ongoing basis its investment in the Issuer and its options with respect to such investment, and now believe that additional changes may be necessary for the Issuer to maximize shareholder value. On February 27, 2026, Veradace shared its concerns with the Issuer regarding the Issuer's performance over the last several years and the absence of any meaningful shareholder perspective on its board of directors (the "Board"). Veradace indicated its desire for two new directors to be added to the Board. Although Veradace does not presently intend to nominate any candidates for election to the Board at the 2026 annual meeting of stockholders, Veradace intends to continue to engage in dialogue with the Issuer regarding potential Board candidates and the opportunity for the Board to benefit from fresh perspectives with respect to investor credibility, capital allocation, and overall value maximization.
As noted above, Veradace intends to evaluate on an ongoing basis its investment in the Issuer and its options with respect to such investment. In connection with such evaluation, the Reporting Persons may communicate publicly or privately with members of the Board and/or senior management of the Issuer, other stockholders, knowledgeable industry or market observers, or other third parties with respect to this investment. As part of such evaluation and any such communications, the Reporting Persons may make recommendations, suggestions, or proposals to and may engage in discussions with the Issuer or other third parties (including other stockholders) that may relate to or result in one or more of the matters specified in clauses (a) through (j) of Item 4 of Schedule 13D, including, but not limited to, changes in the composition of the Board, changes in the strategic direction and future plans of the Issuer and other opportunities involving the Issuer as a means of enhancing shareholder value.
Except as set forth herein, none of the Reporting Persons has any plans or proposals that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Depending on various factors, including the Issuer's financial position, prospects and strategic direction, the outcome of the matters referenced above, other developments concerning the Issuer, actions taken by the Board, price levels of the Shares, other investment opportunities available to the Reporting Person, conditions in the securities markets and general economic and industry conditions, the Reporting Person may in the future take such actions with respect to their investment in the Issuer as it deems appropriate, including, without limitation, (i) acquiring additional securities of the Issuer in the open market or in privately negotiated transactions, (ii) disposing of all or a portion of its securities, and (iii) enter into hedging, derivative or other arrangements with respect to its economic exposure to the Issuer's securities. The Reporting Persons reserve the right to change their views with respect to the Issuer and to take any action with respect to their investment permitted by law.
| |
| Item 5. | Interest in Securities of the Issuer |
| (a) | The aggregate number and percentage of the class of securities identified pursuant to Item 1 beneficially owned by each Reporting Person as of the time of filing, is stated in Items 11 and 13 on the cover page(s) hereto. |
| (b) | The Reporting Persons may be deemed to share voting and dispositive power over 2,039,805 Shares and options to acquire an additional 50,000 Shares, representing beneficial ownership of a combined total of 16.5 percent of the outstanding Shares. |
| (c) | The transactions effected by the Reporting Persons in the Shares during the past 60 days are set forth on Schedule A to this statement. Each of these transactions was executed through the open market. |
| (d) | No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Securities. |
| (e) | Not applicable. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
The information set forth in Item 4 above is incorporated by reference in its entirety in this Item 6.
The Fund, through open market transactions between September 25, 2025 and November 4, 2025, purchased options to acquire 489,300 Shares and sold put options covering the same number of Shares (the call options and put options collectively, the "Options"). All of the Options are American-style and expire on March 20, 2026. The exercise prices for the Options are as set forth below:
Option Exercise Price
50,000 Shares (Call) $10 per Share
100,000 Shares (Sold Put) $7.50 per Share
| |
| Item 7. | Material to be Filed as Exhibits. |
Schedule A: Schedule of Transactions in the Shares of Common Stock of the Issuer (filed herewith). |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
Comments accompanying signature:
This Amendment is being filed solely to include Exhibit 99.1 and Exhibit 99.2, which were inadvertently omitted from the original filing. Except as otherwise set forth herein, the Schedule 13D remains unchanged. |
ATTACHMENTS / EXHIBITS